Republican Sen. Chuck Grassley is objecting to medical research legislation that would weaken a law intended to expose payments from pharmaceutical companies to doctors.

The Senate version of the 21st Century Cures Act was announced Saturday and proposes $6.8 billion in new funding for the National Institutes of Health and the Food and Drug Administration. The package, which would boost medical research and speed up approval of new drugs and devices, has bipartisan support.